GenMark Diagnostics, Inc
GNMK
GNMK was delisted on the 21st of April, 2021.
86 hedge funds and large institutions have $230M invested in GenMark Diagnostics, Inc in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 35 increasing their positions, 24 reducing their positions, and 8 closing their positions.
46% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 24
2% less funds holding
Funds holding: 88 → 86 (-2)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
33% less capital invested
Capital invested by funds: $342M → $230M (-$113M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $4K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.95M |
| 2 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$680K |
| 3 |
Morgan Stanley
New York
|
+$566K |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$486K |
| 5 |
Jennison Associates
New York
|
+$446K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Casdin Capital
New York
|
-$2.41M |
| 2 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
-$1.19M |
| 3 |
JP Morgan Chase
New York
|
-$1.13M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.12M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$835K |
GNMK Hedge Fund Activity: Q1 2016 in Review
86 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q1 2016, worth a combined $230M — down 33% from $342M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of GNMK and 6 opened new positions — a net loss of 2 holders — while 24 trimmed existing stakes and 35 added.
The largest buyer was Adage Capital Partners, adding an estimated $1.95M. The largest seller was Casdin Capital, exiting entirely with an estimated $2.41M sold.
- 86 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q1 2016, down from 88 in Q4 2015.
- Funds reported $230M of GenMark Diagnostics, Inc stock for Q1 2016, down 33% quarter-over-quarter.
- 6 funds opened new GenMark Diagnostics, Inc positions in Q1 2016 and 8 closed out, a net change of -2 holders.
- The largest GenMark Diagnostics, Inc buyer in Q1 2016 was Adage Capital Partners, an estimated $1.95M added.
- The largest GenMark Diagnostics, Inc seller in Q1 2016 was Casdin Capital, an estimated $2.41M sold.
Based on aggregated 13F filings for Q1 2016.